Stem Cell Injections Improved Knee Cartilage in Study
A study in rabbits found that two doses of stem cells helped preserve joint tissue after surgical damage.
Updated on Oct. 1, 2026 in Arthritis
Researchers have found that two intra-articular injections of human adipose-derived mesenchymal stem cells improved cartilage preservation in a rabbit model of knee osteoarthritis. This preclinical finding offers insights into the potential for multi-dose regenerative therapies for joint health.
Why it matters
Understanding the efficacy of different dosing regimens for stem cell therapy is essential for developing future treatments for osteoarthritis. This research helps clarify whether multiple injections can offer superior protection for articular surfaces compared to a single dose.
In a preclinical study, researchers administered human adipose-derived mesenchymal stem cell injections to rabbits with surgically induced osteoarthritis. The results showed that a two-dose regimen increased type II collagen expression and improved surface smoothness compared to a single dose.
The details
To evaluate the efficacy of the therapy, researchers surgically induced osteoarthritis in the animals through anterior cruciate ligament transection and meniscectomy. The treatment works by injecting mesenchymal stem cells directly into the knee joint, which researchers theorize may help modulate the joint environment. The two-dose approach, delivered at six and nine weeks post-surgery, appeared to facilitate better cartilage maintenance than a single administration.
Timeline
Week 6: The initial intra-articular injections were administered to the subjects.
Week 9: The second round of intra-articular injections was delivered.
18 weeks post-surgery: Researchers performed the final collection of samples.
Health Landscape
This study aligns with the ongoing development of regenerative medicine for osteoarthritis as researchers seek to refine therapeutic protocols. It builds upon existing investigations into whether optimizing cell-based delivery methods can successfully slow the progression of joint degradation.
This preclinical study does not change current care, as findings from animal models cannot be applied to human clinical decisions. You should discuss any concerns regarding persistent knee pain or potential regenerative treatments with your physician to understand established therapeutic options.
The takeaway
While multi-dose stem cell injections showed promise in this animal study, these results are preliminary and have not been tested in humans. Patients experiencing joint pain should consult a healthcare provider about evidence-based treatment strategies and the limitations of current experimental therapies.
Further reading
For more information on the current approaches to managing joint conditions, visit our Arthritis section.
More information
View the complete peer-reviewed research article for full study details.
Source note: This article includes information reported by Nature.
